Skip to main content

Wetin na di tritmɛnt dɛm fɔ Stej IV Kɔlɔn Kansa?

Wetin na di tritmɛnt dɛm fɔ Stej IV Kɔlɔn Kansa?

I at fɔ put insay wɔd di frayd ɛn shɔk we kin kam wit we dɛn no se yu gɛt Stej IV kansa. Na nɔmal tin fɔ wɔnda, "I dɔn ɔltin naw?" Bɔt lɛ a tɛl yu, nɔto so i bi. Mɛdikal sayɛns dɔn go bifo bɔku. Ivin na dis stej, bɔrku tritmɛnt de wae kin ɛp yu fɔ liv lɔng, kɔntrol yu sik, ɛn fɔ gɛt wɛl bɔdi. Lɛ wi tɔk bɔt dis simpul wan, di we we yu go ɔndastand.

Wetin na ‘Stej IV’?

Fɔ tɔk am simpul wan, Stej IV min se di kansa dɔn skata pas di kɔlon , usay i bigin. Dis kin apin mɔ to di liva . I kin spre bak to di lכng dεm, di layn na di bכdi, כ di limf no dεm כdasay na di bכdi.

E kin tranga fɔ gɛt ful mɛrɛsin na dis stej. Bɔt if di kansa dɔn skata to sɔm say dɛn nɔmɔ, sɔntɛnde dɛn kin du ɔpreshɔn fɔ pul dɛn say dɛn de kpatakpata ɛn mɛn di sik. So, i go fayn fɔ mek yu go to dɔktɔ we spɛshal fɔ trit dis kayn sik. De tritmɛnt wae yu go gɛt go dipen pan bɔrku tin, lɛk usai de kansa dɔn skata, yu ej, ɛn yu ɔl wɛl bɔdi.

Bɔku men we dɛn de fɔ trit pɔsin:

  • Ɔpreshɔn
  • Kimotɛrapi
  • Redyushɔn tɛrapi
  • Ablashɔn ɛn krayotɛrapi
  • Di tritmɛnt dɛn we dɛn dɔn tɔk bɔt
  • Imyunotɛrapi

Bɔrku tɛm, dɛn kin gi yu pas wan pan dɛn tritmɛnt ya, ɔr dɛn kin gi yu sɔm pan dɛn tritmɛnt ya.

Wetin dɛn kin du wit ɔpreshɔn?

If di kansa dɔn skata to yu liva ɔ yu lɔng, sɔntɛnde dɛn kin du ɔpreshɔn. As a bin dɔn tɔk, if di kansa nɔ bɔku, ɔpreshɔn kin pul am ɛn yu kin wɛl ful wan . Ɔda tɛm dɛn, ɔpreshɔn kin fayn bak fɔ ridyus di sayn dɛn we di kansa kin kam wit, lɛk pen ɛn di bɔdi we nɔ de blo.

We dɛn de du di ɔpreshɔn, di dɔktɔ kin pul di pat pan di kɔlon, liva, ɔ lɔng usay di kansa de. na di sem tεm, dεn kin pul di limf no dεm we de rawnd am. dis na biכs di kεnsar sεl dεm kin izi fכ spre to כda pat dεm na di bכdi tru dεn limf no dεm ya.

Afta di dɔktɔ dɔn pul di pat we gɛt kansa na di kɔlon, i go kɔnɛkt bak di tu ɛnd dɛn na di kɔlon we lɛf. Dɔn yu kin gɛt bɔdi muvmɛnt nɔmal wan. Bɔt sɔntɛnde if dis kɔnekshɔn nɔ pɔsibul, yu kin nid fɔ du kɔlostomi . dis min fכ kכnekt wan εnd pan di kכlon to wan ol we dεn mek na di bכdi in skin. Di stɔl de kɔmɔt tru da ol de. Dɛn kin gɛda di stɔl insay wan pɔch we dɛn tay pan am.

Nɔ wɔri, fɔ bɔku pipul dɛn, dis kɔlostomi na fɔ shɔt tɛm nɔmɔ. Wae di wund dεm we de insay de hεl afta dεn du di כpεrayshכn, dεn kin pul am εn yu go ebul fכ gεt nכmal bכdi muvmεnt bak.

Sɔntɛnde, if dɛn pul wan big pat pan di kɔlon, di ɛnd pan di smɔl intestin kin kɔnɛkt to di skin na di bɛlɛ. Dɛn kɔl dis ileostomy . Bɔt sɔm pen kin de afta di ɔpreshɔn. Yu kin gɛt dayarɛa ɔ kɔnstipɛshɔn bak. Dɛn sayd ɛfɛkt ya go dɔn afta sɔm tɛm.

If kansa dɔn blok di intestinal, dɛn kin put wan smɔl tiub we dɛn kɔl stent fɔ mek i opin.

Wetin na kemotɛrapi?

Kimotɛrapi, ɔ ‘kimo’ as wi kin kɔl am, na pawaful kayn mɛrɛsin we dɛn kin gi fɔ kil kansa sɛl dɛn. Dɛn kin gi dis mɛrɛsin insay di bɛlɛ ɔ as pil.

Dɛn kin gi kemotɛrapi bɔku men we dɛn:

  • Bifo dɛn du di ɔpreshɔn, dɛn kin shrink di kansa tumɔs dɛn fɔ mek i izi fɔ pul dɛn.
  • Afta dɛn dɔn du di ɔpreshɔn, pwɛl ɛni kansa sɛl we go lɛf na di bɔdi.
  • As di men tritmɛnt fɔ di wan dɛn we nɔ ebul fɔ du ɔpreshɔn.

Bɔku kayn kemo drɔgs de we dɛn kin gi fɔ stej 4 kɔlon kansa. Sɔntɛnde, dɛn kin gi pas wan pan dɛn mɛrɛsin ya togɛda. Dɔn bak, dɛn kin gi kemo togɛda wit ‘targeted therapy’, we wi go tɔk bɔt leta.

Di Kɔmɔn Sayd Ɛfɛkt dɛn we Kimotɛrapi kin gɛt
🤢 Nɔs ɛn vɔmit 😩 Na yu mɔt sos
🚽 Dayrɛa we pɔsin kin gɛt ✋🏽 Di limbs, tingling, ɛn wik na di limb dɛm
🤒 I izi fɔ gɛt infɛkshɔn 😴 I dɔn taya

Wan tin we bɔku pipul dɛn kin fred we dɛn yɛri bɔt kemo na we dɛn ia kin lɔs. Bɔt,Bɔku tɛm, kemotɛrapi fɔ kɔlon kansa nɔ kin mek yu ia lɔs. Nɔ fred fɔ dɛn sayd ɛfɛkt ya. Yu dɔktɔ kin ɛp yu fɔ manej dɛn ɛn mek dɛn fil fayn. Dɛn sayd ɛfɛkt ya go dɔn smɔl smɔl wans yu tritmɛnt dɔn.

If di kansa dɔn skata to di liva, dɛn kin gi kemotɛrapi bak bay we dɛn yuz wan spɛshal we we dɛn kɔl "hepatic artery infusion chemotherapy." Dis min se yu fɔ injɛkt di kemotɛrapi dairekt insay di men blɔd vesel we de gi blɔd to di liva we yu de yuz pɔmp. Bikɔs di mɛrɛsin kin go dairekt to di liva pas fɔ travul ɔlsay na di bɔdi, dis we ya kin ridyus di sayd ɛfɛkt dɛn ɛn gi di mɛrɛsin mɔ doz.

Radiation therapy ɛn ɔda we dɛn

Rɛdieshɔn Tɛrapi

Dis min se dɛn fɔ yuz ɛkstrem rayt we gɛt bɔku ɛnaji fɔ pwɛl di kansa sɛl dɛn. Pan ɔl we dis tritmɛnt nɔ go ebul fɔ mɛn stej 4 kansa kpatakpata, i kin ɛp fɔ mek di tumbu smɔl ɛn ridyus di sayn dɛn lɛk pen . Dɛn kin gi dis tritmɛnt 5 dez insay di wik fɔ sɔm wik.

Ablashɔn ɛn Krayotɛrapi

Bɔku tɛm dɛn kin yuz dɛn tu we ya fɔ pwɛl di kansa sɛl dɛn we dɔn skata na di liva. Ablashɔn de yuz ɔt , we krayotɛrapi de yuz kol pasmak . We di dɔktɔ yuz CT ɔ ɔltra saund skan, i kin sɛn wan tin we tan lɛk nidul to di tumbu ɛn i kin wam am ɔ friz am fɔ pwɛl di kansa sɛl dɛn.

Targeted Therapy ɛn Immunotherapy - Stet-ɔf-di-at Tritmɛnt dɛn

Dis na tu pan di nyu we dɛn we dɛn kin yuz fɔ mɛn kansa ɛn we kin wok fayn.

Targeted Therapies we dɛn kin yuz fɔ mɛn pipul dɛn

Fɔ tɔk am simpul wan, dɛn mɛrɛsin ya kin spɛshal fɔ di kansa sɛl dɛn. Dɛn kin blok di tin dɛn we di kansa sɛl dɛn nid fɔ gro ɛn skata. Dis kin mek di sɛl dɛn we gɛt wɛlbɔdi nɔ pwɛl bɛtɛ.

  • Anti-angiogenesis drugs: Dɛn wan ya de wok bay we dɛn de stɔp di growth fɔ nyu blɔd vesel dɛm we de it di kansa. I tan lɛk se yu de stɔp di kansa fɔ it. Bevacizumab (Avastin) ɛn Ramucirumab (Cyramza) na dɛn kayn mɛrɛsin ya.
  • EGFR inhibitors: Drug dεm lεk Cetuximab (Erbitux) εn Panitumumab (Vectibix) de blכk wan protin we dεn kכl EGFR we de εp di kεnsar sεl dεm fכ gro. כltu, fכ dεn dכg dεm ya fכ wok, di kεnsar fכ gεt mכtεshכn insay sכm jin dεm (KRAS, NRAS, BRAF). Yu dɔktɔ go tɛst fɔ si if dɛn mɛrɛsin ya fayn fɔ yu.
  • Ɔda drɔgs dɛm: Mɔdan drɔgs dɛm lɛk Encorafenib (Braftovi) ɛn Entectinib (Rozlytrek) de bak tide we de tɔch kansa dɛm wit spɛshal jɛnɛtik muteshon dɛm lɛk BRAF, NTRK, ɛn RET.

Imyunotɛrapi

Dis na tritmɛnt we rili wɔndaful. Wetin yu de du ya na fɔ mek yu yon bɔdi in imyun sistɛm wok ɛn yuz am fɔ fɛt di kansa sɛl dɛn.

wi imyun sistεm gεt protin dεm we dεn kכl PD-1 we de wok lεk brek. Di kansa sɛl dɛn kin yuz dɛn brek ya fɔ avɔyd di imyun sistɛm. Imyun chɛkpoint inhibito drɔgs lɛk Nivolumab (Opdivo) ɛn Pembrolizumab (Keytruda) de wok bay we dɛn ɔf dɛn brek ya. Dis kin mek di imyun sistɛm no ɛn atak di kansa.

Impɔtant: Imyunotɛrapi kin mek di imyun sistɛm wok pasmak, sɔm tɛm dɛn kin atak di ɔgan dɛn we gɛt wɛlbɔdi na di bɔdi (lɛk di lɔng, liva, intestinal). So , i impɔtant fɔ ripɔt ɛni nyu sayn we yu gɛt we yu de trit yu dɔktɔ kwik kwik wan.

Yu tritmɛnt plan

De kayn tritmɛnt wae yu kin gɛt kin dipen pan bɔrku tin. Yu dɔktɔ go mek wan tritmɛnt plan we go spɛshal fɔ yu, ɛn i go tek tɛm tink bɔt tin dɛn lɛk usay di kansa dɔn skata, yu ej, yu ɔl yu wɛlbɔdi, ɛn di jenɛtik kwaliti dɛn we di kansa gɛt.

Yu kin gɛt di chans bak fɔ tek pat pan klinik trial dɛm we de tɛst nyu mɛrɛsin ɛn tritmɛnt dɛm ɔlsay na di wɔl. Dis na fayn chans fɔ tray nyu tritmɛnt. Tɔk to yu dɔktɔ bɔt dat bak.

Mɛsej we dɛn kin kɛr go na os

  • Ivin if yu gɛt stej 4 kɔlon kansa, na sik we yu kin mɛn . Nɔ giv ɔp fɔ op.
  • Di tritmɛnt we yu de gɛt na fɔ yu nɔmɔ . Na yu dɔktɔ kin disayd am, afta yu dɔn tek tɛm stɔdi yu sik.
  • Bɔku tritmɛnt dɛn de we yu kin gɛt, lɛk ɔpreshɔn, kemotɛrapi, tritmɛnt we dɛn want fɔ mɛn, ɛn imyunotɛrapi.
  • Di bad tin dɛn we kin apin we pɔsin gɛt tritmɛnt kin apin, bɔt dɛn kin ebul fɔ kɔntrol dɛn . Tɔk opin wan wit yu dɔktɔ bɔt ɛni prɔblɛm we yu fil.
  • Di mɔ yu no, na di mɔ yu go gɛt pawa fɔ disayd bɔt aw fɔ kia fɔ yu. So nɔ fred fɔ aks kwɛstyɔn .

Kɔlɔn Kansa, Stej IV Kɔlɔn Kansa, Kansa Tritmɛnt, Kimotɛrapi, Ɔpreshɔn, Targeted Tɛrapi, Imyunotɛrapi
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 7 + 1 =
Wetin na di tritmɛnt dɛm fɔ Stej IV Kɔlɔn Kansa?

Wetin na di tritmɛnt dɛm fɔ Stej IV Kɔlɔn Kansa?

I at fɔ put insay wɔd di frayd ɛn shɔk we kin kam wit we dɛn no se yu gɛt Stej IV kansa. Na nɔmal tin fɔ wɔnda, "I dɔn ɔltin naw?" Bɔt lɛ a tɛl yu, nɔto so i bi. Mɛdikal sayɛns dɔn go bifo bɔku. Ivin na dis stej, bɔrku tritmɛnt de wae kin ɛp yu fɔ liv lɔng, kɔntrol yu sik, ɛn fɔ gɛt wɛl bɔdi. Lɛ wi tɔk bɔt dis simpul wan, di we we yu go ɔndastand.

Wetin na ‘Stej IV’?

Fɔ tɔk am simpul wan, Stej IV min se di kansa dɔn skata pas di kɔlon , usay i bigin. Dis kin apin mɔ to di liva . I kin spre bak to di lכng dεm, di layn na di bכdi, כ di limf no dεm כdasay na di bכdi.

E kin tranga fɔ gɛt ful mɛrɛsin na dis stej. Bɔt if di kansa dɔn skata to sɔm say dɛn nɔmɔ, sɔntɛnde dɛn kin du ɔpreshɔn fɔ pul dɛn say dɛn de kpatakpata ɛn mɛn di sik. So, i go fayn fɔ mek yu go to dɔktɔ we spɛshal fɔ trit dis kayn sik. De tritmɛnt wae yu go gɛt go dipen pan bɔrku tin, lɛk usai de kansa dɔn skata, yu ej, ɛn yu ɔl wɛl bɔdi.

Bɔku men we dɛn de fɔ trit pɔsin:

  • Ɔpreshɔn
  • Kimotɛrapi
  • Redyushɔn tɛrapi
  • Ablashɔn ɛn krayotɛrapi
  • Di tritmɛnt dɛn we dɛn dɔn tɔk bɔt
  • Imyunotɛrapi

Bɔrku tɛm, dɛn kin gi yu pas wan pan dɛn tritmɛnt ya, ɔr dɛn kin gi yu sɔm pan dɛn tritmɛnt ya.

Wetin dɛn kin du wit ɔpreshɔn?

If di kansa dɔn skata to yu liva ɔ yu lɔng, sɔntɛnde dɛn kin du ɔpreshɔn. As a bin dɔn tɔk, if di kansa nɔ bɔku, ɔpreshɔn kin pul am ɛn yu kin wɛl ful wan . Ɔda tɛm dɛn, ɔpreshɔn kin fayn bak fɔ ridyus di sayn dɛn we di kansa kin kam wit, lɛk pen ɛn di bɔdi we nɔ de blo.

We dɛn de du di ɔpreshɔn, di dɔktɔ kin pul di pat pan di kɔlon, liva, ɔ lɔng usay di kansa de. na di sem tεm, dεn kin pul di limf no dεm we de rawnd am. dis na biכs di kεnsar sεl dεm kin izi fכ spre to כda pat dεm na di bכdi tru dεn limf no dεm ya.

Afta di dɔktɔ dɔn pul di pat we gɛt kansa na di kɔlon, i go kɔnɛkt bak di tu ɛnd dɛn na di kɔlon we lɛf. Dɔn yu kin gɛt bɔdi muvmɛnt nɔmal wan. Bɔt sɔntɛnde if dis kɔnekshɔn nɔ pɔsibul, yu kin nid fɔ du kɔlostomi . dis min fכ kכnekt wan εnd pan di kכlon to wan ol we dεn mek na di bכdi in skin. Di stɔl de kɔmɔt tru da ol de. Dɛn kin gɛda di stɔl insay wan pɔch we dɛn tay pan am.

Nɔ wɔri, fɔ bɔku pipul dɛn, dis kɔlostomi na fɔ shɔt tɛm nɔmɔ. Wae di wund dεm we de insay de hεl afta dεn du di כpεrayshכn, dεn kin pul am εn yu go ebul fכ gεt nכmal bכdi muvmεnt bak.

Sɔntɛnde, if dɛn pul wan big pat pan di kɔlon, di ɛnd pan di smɔl intestin kin kɔnɛkt to di skin na di bɛlɛ. Dɛn kɔl dis ileostomy . Bɔt sɔm pen kin de afta di ɔpreshɔn. Yu kin gɛt dayarɛa ɔ kɔnstipɛshɔn bak. Dɛn sayd ɛfɛkt ya go dɔn afta sɔm tɛm.

If kansa dɔn blok di intestinal, dɛn kin put wan smɔl tiub we dɛn kɔl stent fɔ mek i opin.

Wetin na kemotɛrapi?

Kimotɛrapi, ɔ ‘kimo’ as wi kin kɔl am, na pawaful kayn mɛrɛsin we dɛn kin gi fɔ kil kansa sɛl dɛn. Dɛn kin gi dis mɛrɛsin insay di bɛlɛ ɔ as pil.

Dɛn kin gi kemotɛrapi bɔku men we dɛn:

  • Bifo dɛn du di ɔpreshɔn, dɛn kin shrink di kansa tumɔs dɛn fɔ mek i izi fɔ pul dɛn.
  • Afta dɛn dɔn du di ɔpreshɔn, pwɛl ɛni kansa sɛl we go lɛf na di bɔdi.
  • As di men tritmɛnt fɔ di wan dɛn we nɔ ebul fɔ du ɔpreshɔn.

Bɔku kayn kemo drɔgs de we dɛn kin gi fɔ stej 4 kɔlon kansa. Sɔntɛnde, dɛn kin gi pas wan pan dɛn mɛrɛsin ya togɛda. Dɔn bak, dɛn kin gi kemo togɛda wit ‘targeted therapy’, we wi go tɔk bɔt leta.

Di Kɔmɔn Sayd Ɛfɛkt dɛn we Kimotɛrapi kin gɛt
🤢 Nɔs ɛn vɔmit 😩 Na yu mɔt sos
🚽 Dayrɛa we pɔsin kin gɛt ✋🏽 Di limbs, tingling, ɛn wik na di limb dɛm
🤒 I izi fɔ gɛt infɛkshɔn 😴 I dɔn taya

Wan tin we bɔku pipul dɛn kin fred we dɛn yɛri bɔt kemo na we dɛn ia kin lɔs. Bɔt,Bɔku tɛm, kemotɛrapi fɔ kɔlon kansa nɔ kin mek yu ia lɔs. Nɔ fred fɔ dɛn sayd ɛfɛkt ya. Yu dɔktɔ kin ɛp yu fɔ manej dɛn ɛn mek dɛn fil fayn. Dɛn sayd ɛfɛkt ya go dɔn smɔl smɔl wans yu tritmɛnt dɔn.

If di kansa dɔn skata to di liva, dɛn kin gi kemotɛrapi bak bay we dɛn yuz wan spɛshal we we dɛn kɔl "hepatic artery infusion chemotherapy." Dis min se yu fɔ injɛkt di kemotɛrapi dairekt insay di men blɔd vesel we de gi blɔd to di liva we yu de yuz pɔmp. Bikɔs di mɛrɛsin kin go dairekt to di liva pas fɔ travul ɔlsay na di bɔdi, dis we ya kin ridyus di sayd ɛfɛkt dɛn ɛn gi di mɛrɛsin mɔ doz.

Radiation therapy ɛn ɔda we dɛn

Rɛdieshɔn Tɛrapi

Dis min se dɛn fɔ yuz ɛkstrem rayt we gɛt bɔku ɛnaji fɔ pwɛl di kansa sɛl dɛn. Pan ɔl we dis tritmɛnt nɔ go ebul fɔ mɛn stej 4 kansa kpatakpata, i kin ɛp fɔ mek di tumbu smɔl ɛn ridyus di sayn dɛn lɛk pen . Dɛn kin gi dis tritmɛnt 5 dez insay di wik fɔ sɔm wik.

Ablashɔn ɛn Krayotɛrapi

Bɔku tɛm dɛn kin yuz dɛn tu we ya fɔ pwɛl di kansa sɛl dɛn we dɔn skata na di liva. Ablashɔn de yuz ɔt , we krayotɛrapi de yuz kol pasmak . We di dɔktɔ yuz CT ɔ ɔltra saund skan, i kin sɛn wan tin we tan lɛk nidul to di tumbu ɛn i kin wam am ɔ friz am fɔ pwɛl di kansa sɛl dɛn.

Targeted Therapy ɛn Immunotherapy - Stet-ɔf-di-at Tritmɛnt dɛn

Dis na tu pan di nyu we dɛn we dɛn kin yuz fɔ mɛn kansa ɛn we kin wok fayn.

Targeted Therapies we dɛn kin yuz fɔ mɛn pipul dɛn

Fɔ tɔk am simpul wan, dɛn mɛrɛsin ya kin spɛshal fɔ di kansa sɛl dɛn. Dɛn kin blok di tin dɛn we di kansa sɛl dɛn nid fɔ gro ɛn skata. Dis kin mek di sɛl dɛn we gɛt wɛlbɔdi nɔ pwɛl bɛtɛ.

  • Anti-angiogenesis drugs: Dɛn wan ya de wok bay we dɛn de stɔp di growth fɔ nyu blɔd vesel dɛm we de it di kansa. I tan lɛk se yu de stɔp di kansa fɔ it. Bevacizumab (Avastin) ɛn Ramucirumab (Cyramza) na dɛn kayn mɛrɛsin ya.
  • EGFR inhibitors: Drug dεm lεk Cetuximab (Erbitux) εn Panitumumab (Vectibix) de blכk wan protin we dεn kכl EGFR we de εp di kεnsar sεl dεm fכ gro. כltu, fכ dεn dכg dεm ya fכ wok, di kεnsar fכ gεt mכtεshכn insay sכm jin dεm (KRAS, NRAS, BRAF). Yu dɔktɔ go tɛst fɔ si if dɛn mɛrɛsin ya fayn fɔ yu.
  • Ɔda drɔgs dɛm: Mɔdan drɔgs dɛm lɛk Encorafenib (Braftovi) ɛn Entectinib (Rozlytrek) de bak tide we de tɔch kansa dɛm wit spɛshal jɛnɛtik muteshon dɛm lɛk BRAF, NTRK, ɛn RET.

Imyunotɛrapi

Dis na tritmɛnt we rili wɔndaful. Wetin yu de du ya na fɔ mek yu yon bɔdi in imyun sistɛm wok ɛn yuz am fɔ fɛt di kansa sɛl dɛn.

wi imyun sistεm gεt protin dεm we dεn kכl PD-1 we de wok lεk brek. Di kansa sɛl dɛn kin yuz dɛn brek ya fɔ avɔyd di imyun sistɛm. Imyun chɛkpoint inhibito drɔgs lɛk Nivolumab (Opdivo) ɛn Pembrolizumab (Keytruda) de wok bay we dɛn ɔf dɛn brek ya. Dis kin mek di imyun sistɛm no ɛn atak di kansa.

Impɔtant: Imyunotɛrapi kin mek di imyun sistɛm wok pasmak, sɔm tɛm dɛn kin atak di ɔgan dɛn we gɛt wɛlbɔdi na di bɔdi (lɛk di lɔng, liva, intestinal). So , i impɔtant fɔ ripɔt ɛni nyu sayn we yu gɛt we yu de trit yu dɔktɔ kwik kwik wan.

Yu tritmɛnt plan

De kayn tritmɛnt wae yu kin gɛt kin dipen pan bɔrku tin. Yu dɔktɔ go mek wan tritmɛnt plan we go spɛshal fɔ yu, ɛn i go tek tɛm tink bɔt tin dɛn lɛk usay di kansa dɔn skata, yu ej, yu ɔl yu wɛlbɔdi, ɛn di jenɛtik kwaliti dɛn we di kansa gɛt.

Yu kin gɛt di chans bak fɔ tek pat pan klinik trial dɛm we de tɛst nyu mɛrɛsin ɛn tritmɛnt dɛm ɔlsay na di wɔl. Dis na fayn chans fɔ tray nyu tritmɛnt. Tɔk to yu dɔktɔ bɔt dat bak.

Mɛsej we dɛn kin kɛr go na os

  • Ivin if yu gɛt stej 4 kɔlon kansa, na sik we yu kin mɛn . Nɔ giv ɔp fɔ op.
  • Di tritmɛnt we yu de gɛt na fɔ yu nɔmɔ . Na yu dɔktɔ kin disayd am, afta yu dɔn tek tɛm stɔdi yu sik.
  • Bɔku tritmɛnt dɛn de we yu kin gɛt, lɛk ɔpreshɔn, kemotɛrapi, tritmɛnt we dɛn want fɔ mɛn, ɛn imyunotɛrapi.
  • Di bad tin dɛn we kin apin we pɔsin gɛt tritmɛnt kin apin, bɔt dɛn kin ebul fɔ kɔntrol dɛn . Tɔk opin wan wit yu dɔktɔ bɔt ɛni prɔblɛm we yu fil.
  • Di mɔ yu no, na di mɔ yu go gɛt pawa fɔ disayd bɔt aw fɔ kia fɔ yu. So nɔ fred fɔ aks kwɛstyɔn .

Kɔlɔn Kansa, Stej IV Kɔlɔn Kansa, Kansa Tritmɛnt, Kimotɛrapi, Ɔpreshɔn, Targeted Tɛrapi, Imyunotɛrapi
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 7 + 1 =